Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chronic obstructive pulmonary disease Age: Adult |
Dose: Inhaler – 2 puffs (18 mcg) Frequency: once daily |
|
Indication: Chronic obstructive pulmonary disease Age: Adult |
Dose: Inhalation capsule – 1 capsule (18 mcg) Frequency: once daily Note: via inhaler device, at the same time each day |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Chronic obstructive pulmonary disease Age: greater than 12 years |
Dose: Inhaler – 2 puffs (18 mcg) Frequency: once daily |
|
Indication: Chronic obstructive pulmonary disease Age: greater than 18 years |
Dose: Inhalation capsule – 1 capsule (18 mcg) Frequency: once daily Note: via inhaler device, at the same time each day |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Dosage Recommendation – Use with caution Note: Renal impairment: CrCl (ml/min) Dosage Recommendation less than 50 Use with caution. |
Administration
- Inhale as directed
- Use at same time daily
Side Effect
- Upper respiratory tract infection (URTI) (41%)
- Dry mouth (16%)
- Sinusitis (11%)
- Abdominal pain
- Allergic reaction
- Angina pectoris (including aggravated angina pectoris)
- Cataract
- Chest pain (nonspecific)
- Constipation
- Depression
- Dyspepsia
- Dysphonia
- Edema
- Epistaxis
- Gastroesophageal reflux
- Herpes zoster
- Hypercholesterolemia
- Hyperglycemia
- Infection
- Laryngitis
- Leg pain
- Moniliasis
- Myalgia
- Paresthesia
- Pharyngitis
- Rash
- Rhinitis
- Skeletal pain
- Stomatitis (including ulcerative stomatitis)
- Urinary Tract Infection (UTI)
- Vomiting
- Angioedema
- Fibrillation
- Supraventricular tachycardia
- Urinary retention
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Other anticholinergic agents
|
Interaction noted, but effect not specified
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Hypersensitivity to Atropine derivatives
|
Risk of allergic reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Tiotropium Dry Powder Inhaler capsules must not be swallowed. Avoid storage in direct sunlight or heat. Store below 30°C. Keep away from children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.